Immunoinformatics‐Based Multi‐Epitope Vaccine Targeting Helicobacter Pylori
Cancer Reports · 2026
DOI: 10.1002/cnr2.70441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2026. Verfasst von Aytak Vahdat Khajeh Pasha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, TeMS.C., Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Helicobacter pylori, Bacterial Vaccines, Computational Biology, Helicobacter Infections. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The rising global incidence of Helicobacter pylori ‐related diseases, particularly gastric cancer, underscores the urgent need for effective preventive vaccines, motivating the exploration of innovative immunoinformatic strategies to address this public health challenge.
Aims
The aim of this study was to design a multi‐epitope subunit vaccine for Helicobacter pylori using an immunoinformatics approach. Specifically, the objectives were to predict potential epitopes from the flagellin B and urease B proteins, integrate the cholera toxin B subunit (CTB) as a mucosal adjuvant, and perform computational validation of the vaccine construct for antigenicity, stability, and interaction with immune receptors.
Methods
This study utilized an immunoinformatics approach to design a multi‐epitope subunit vaccine, involving epitope prediction from flagellin B and urease B, integration of the cholera toxin B subunit (CTB) as a mucosal adjuvant, and computational validation through tools like VaxiJen, Phyre2, MolProbity, and HDOCK for antigenicity, structure, and docking analysis.
Results
The resulting vaccine construct comprises 406 amino acids with a molecular weight of 43 424.77 Da, exhibiting a predicted antigenic score of 1.0084, non‐allergenic and non‐toxic properties, and a stable physiochemical profile (instability index 23.51, GRAVY −0.425). Structural analysis suggested 99.1% (525/530) of residues in favored Ramachandran regions and 100.0% in allowed regions. Molecular docking with Toll‐like receptor 5 (TLR5) indicated a superior docking score of −309.05 and a confidence score of 0.9601, outperforming TLR2 (−250.74), with 10 CTL epitopes (6 from flagellin B, 4 from urease B), 6 HTL epitopes, and 2 LBL epitopes linked by AAY, GPGPG, and KK linkers, respectively.
Conclusion
This research provides a computationally optimized vaccine design that shows potential for eliciting immune responses against H. pylori . Importantly, the findings remain entirely theoretical and require rigorous experimental validation in vitro and in vivo to assess their immunological relevance, safety, and efficacy before any translational or clinical application can be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, TeMS.C., Islamic Azad University, Tehran, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Aytak Vahdat Khajeh Pasha, Mohammad Esfandiyari, Alireza Parnian, Mohammad Mahboubi-Rabbani, Maryam Bayanati
Zitieren
APA
Pasha, A. V. K., Esfandiyari, M., Parnian, A., Mahboubi-Rabbani, M., & Bayanati, M. (2026). Immunoinformatics‐Based Multi‐Epitope Vaccine Targeting Helicobacter Pylori. Cancer Reports. https://doi.org/10.1002/cnr2.70441
Vancouver
Pasha AVK, Esfandiyari M, Parnian A, Mahboubi-Rabbani M, Bayanati M. Immunoinformatics‐Based Multi‐Epitope Vaccine Targeting Helicobacter Pylori. Cancer Reports. 2026. doi:10.1002/cnr2.70441
BibTeX
@article{Pasha2026,
author = {Pasha, Aytak Vahdat Khajeh and Esfandiyari, Mohammad and Parnian, Alireza and Mahboubi-Rabbani, Mohammad and Bayanati, Maryam},
title = {Immunoinformatics‐Based Multi‐Epitope Vaccine Targeting Helicobacter Pylori},
journal = {Cancer Reports},
year = {2026},
doi = {10.1002/cnr2.70441}
}
EUVIMED